Skadden, Arps, Slate, Meagher & Flom acted as legal advisor, and Pinheiro Neto Advogados as legal advisor on Brazilian matters to Semantix. Davis Polk & Wardwell […]
Semantix’s Merger with Alpha Capital
Indorama’s $1.3 Billion Acquisition of Ultrapar’s Chemical Unit
Lowenstein, Beccar Varela, and Mattos Filho, Veiga Filho, Marrey Jr. E Quiroga advised Indorama Ventures on the deal. Skadden, Stocche Forbes, BMA – Barbosa, Müssnich, Aragão […]
Indorama Ventures’ $1.3 Billion Acquisition of Oxiteno
Skadden, Arps, Slate, Meagher & Flom represented Ultrapar Participações in the transaction. Indorama Ventures Public Company Limited (IVL), a global chemicals producer, agreed to acquire Brazil-based […]
Clear Sale’s $220.3 Million Initial Public Offering
Skadden, Arps, Slate, Meagher & Flom LLP represented Itaú BBA, BofA Securities, BTG Pactual and Santander in the offering. Clear Sale S.A. executed the 1.14 billion Brazilian […]
WDC Networks’ R$450.1 Million Initial Public Offering
Skadden, Arps, Slate, Meagher & Flom represented Livetech da Bahia Indústria e Comércio S.A. in the offering. Shearman & Sterling represented BTG Pactual, Bradesco BBI, Itaú […]
Banco BTG Pactual’s $250 Million Senior Notes Reopening
Skadden, Arps, Slate, Meagher & Flom and BMA – Barbosa, Müssnich, Aragão represented Banco BTG Pactual in the transaction. Simpson Thacher and Tauil & Chequer (Mayer […]
Banco BTG Pactual’s $595 Million Shares Offering
Skadden, Arps, Slate, Meagher & Flom and Barbosa, Müssnich, Aragão represented Banco BTG Pactual S.A. in the offering, while Simpson Thacher and Tauil & Chequer Advogados […]
PetroRecôncavo’s R$1,032.5 Million Initial Public Offering
Skadden, Arps, Slate, Meagher & Flom LLP and BMA – Barbosa, Müssnich, Aragão represented PetroRecôncavo S.A. in the transaction. Hogan Lovells and acted as international counsel […]
Allied Tecnologia’s $33.8 Million Initial Public Offering
Skadden represented Allied Tecnologia S.A. in the transaction. Allied Tecnologia S.A. completed its R$188.6 million (US$33.8 million) (excluding the underwriters’ over-allotment option) primary and secondary initial […]